Practice Point CME

Your Sorted CME/CE Activities

Number of search result: 50

Quarterly Brief (October - December, 2018): A Current Expert Analysis on Important HIV Clinical Decisions

Activity Details

Quarterly Brief (October - December, 2018): A Current Expert Analysis on Important HIV Clinical Decisions

Activity Summary:
New frontiers for HIV therapy continue to be explored, as underscored by the clinical development and use of new agents, changing regimen strategies and development of long-acting novel agents. This expanding era of simplified and effective HIV therapy presents physicians with many new opportunities and challenges for providing care. To deliver state-of-the-art HIV prevention and care, healthcare providers must stay informed regularly of new clinical data and treatment recommendations in HIV.

These educational Quarterly Briefs will discuss changing guidelines, evolving treatment options, and side-effect considerations in the management of patients with HIV as well as an update on HIV prevention.

Faculty:Paul Sax, MD and Monica Gandhi, MD, MPH

Accreditation Type:AMA, ANCC and ACPE

Release Date:January 16, 2019

Expiration Date: December 31, 2019

Estimated Time to Complete Activity:0.5 Hours

ACCESS THIS ACTIVITY

Independent Conference Coverage from the 2018 Annual Meeting of the American Association for the Study of Liver Disease (AASLD)*

Activity Details

Independent Conference Coverage from the 2018 Annual Meeting of the American Association for the Study of Liver Disease (AASLD)*

Activity Summary:
Recognizing and discussing significant developments and strategies in HCV therapy places healthcare professionals at the forefront of hepatitis care. This activity will explain how recent study results in HCV apply to clinical practice, discuss significant developments and strategies in HCV therapy, discuss results from key clinical studies on new antiviral therapy, and describe recent data on drug toxicity/adverse events, drug interactions, and strategies for HCV management.

These educational Clinical Clips will spotlight the latest advances in the prevention and treatment of hepatitis C through a series of daily, ‘what you need to know in 5-minutes’ videos each day from AASLD 2018.

Faculty:Sammy Saab, MD, MPH, AGAF, FAASLD, FACG

Accreditation Type:AMA, ANCC and ACPE

Release Date:November 10, 2018

Expiration Date: October 31, 2019

Estimated Time to Complete Activity:0.25 Hours per Clip; 1.0 Hours for Wrap Up Archive

ACCESS THIS ACTIVITY

Pulmonary Hypertension for Urgent Care / Emergency Providers

Activity Details

Pulmonary Hypertension for Urgent Care / Emergency Providers

Activity Summary:
Research shows that there is as much as a 2-year median lag between the time patients present with symptoms associated with PAH and a definitive diagnosis through right-heart catheterization. Millions of patients are seen annually in emergency and urgent care settings, often as their single point of contact with the US healthcare system.

These educational mini modules will outline the hallmarks of various forms of pulmonary hypertension, including PAH, in the hopes of triggering earlier referral for specific screening and diagnostic testing. In addition, recommendations for dealing with the already diagnosed PAH patient who presents for emergent/urgent care will be discussed.

Faculty:Richard Channick, MD

Accreditation Type:AMA, ANCC and ACPE

Release Date:November 8, 2018

Expiration Date: October 31, 2019

Estimated Time to Complete Activity:.50 Hours per Module

ACCESS THIS ACTIVITY

Independent Coverage from HIV Drug Therapy, Glasgow 2018*

Activity Details

Independent Coverage from HIV Drug Therapy, Glasgow 2018*

Activity Summary:
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

These educational Clinical Clips will spotlight the latest advances in the prevention and treatment of HIV through a series of ‘what you need to know in 5-minutes’ videos from HIV Drug Therapy, Glasgow.

Faculty:Chloe Orkin, FRCP, MD

Accreditation Type:AMA, ANCC and ACPE

Release Date:October 30, 2018

Expiration Date: September 30, 2019

Estimated Time to Complete Activity:0.25 Hours per Clip

ACCESS THIS ACTIVITY

Advanced Topics in Pulmonary Arterial Hypertension II – Updated 10/25/18

Activity Details

Advanced Topics in Pulmonary Arterial Hypertension II – Updated 10/25/18

Activity Summary:
Clinicians who treat patients with PAH need to integrate a wide range of diagnostic and treatment strategies into their clinical management armamentarium.

These educational Mini Modules will outline recent advances in diagnostic and prognostic imaging techniques for patients with PAH, the role of cardiopulmonary rehabilitation in the management of PAH, and the characteristics that distinguish the clinical entity known as combined pre- and post-capillary PH (Cpc-PH) from other types of PH/PAH.

Updated information is noted on the slide in the upper right-hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Faculty:Franz Rischard, DO

Accreditation Type:AMA, ANCC and ACPE

Release Date:July 17, 2018

Expiration Date: June 30, 2019

Estimated Time to Complete Activity:.50 Hours per Module

ACCESS THIS ACTIVITY

Quality of Life and Patient-Reported Outcomes in PAH

Activity Details

Quality of Life and Patient-Reported Outcomes in PAH

Activity Summary:
The goal of PAH therapy should be not merely to lengthen a patient’s lifespan, but to allow them to fully participate in day-to-day activities. Traditional methods of monitoring patient progress on therapy and/or disease progression often overlook aspects of living that are most important to the patient. In addition, patients often are reluctant to discuss these matters with their clinicians.

These educational mini modules will outline quality-of-life measurements and patient-reported outcomes in PAH, how those measures intersect with traditional clinical outcomes, and how those measurements can be applied to clinical practice.

Faculty:Ronald Oudiz, MD

Accreditation Type:AMA, ANCC and ACPE

Release Date:October 25, 2018

Expiration Date: September 30, 2019

Estimated Time to Complete Activity:.50 Hours per Module

ACCESS THIS ACTIVITY

Quarterly Brief (July-September, 2018):<br> A Current Expert Analysis on Important HIV Clinical Decisions

Activity Details

Quarterly Brief (July-September, 2018):<br> A Current Expert Analysis on Important HIV Clinical Decisions

Faculty:Paul Sax, MD and Eric Daar, MD

Accreditation Type:AMA, ANCC and ACPE

Release Date:October 17, 2018

Expiration Date: September 30, 2019

Estimated Time to Complete Activity:0.5 Hours

ACCESS THIS ACTIVITY

Independent Conference Coverage from the American College of Chest Physicians Annual Meeting 2018*

Activity Details

Independent Conference Coverage from the American College of Chest Physicians Annual Meeting 2018*

Activity Summary:
Despite dramatic advances in the development of treatments for pulmonary arterial hypertension (PAH), it remains a chronic life-threatening illness for which there is no cure. Advances in knowledge in the field are eagerly anticipated.

These educational Clinical Clips® will spotlight important research into the basic science, diagnosis, treatment, and medical management of patients with PAH based on data presented at the the American College of Chest Physicians Annual Meeting in San Antonio, Texas, October 6-10 2018, through a series of two ‘what you need to know in 5-minutes’ videos.

Faculty:Nicholas Hill, MD

Accreditation Type:AMA, ANCC and ACPE

Release Date:October 8, 2018

Expiration Date: September 30, 2019

Estimated Time to Complete Activity:0.25 Hours per Clip

ACCESS THIS ACTIVITY

Pediatric Pulmonary Vascular Disease

Activity Details

Pediatric Pulmonary Vascular Disease

Activity Summary:
PAH is a rapidly progressive life-threatening condition in children. Improved awareness among primary care clinicians and others who care for children is essential to raise awareness of the differences in presenting symptoms and diagnostic screening for this rare condition compared with other common complaints.

These educational mini modules will outline screening and diagnosis, general care measures, and PAH-specific therapy, including children with congenital heart disease-related PH.

Faculty:Dunbar Ivy, MD & Usha Krishnan, MD

Accreditation Type:AMA, ANCC and ACPE

Release Date:September 11, 2018

Expiration Date: August 31, 2019

Estimated Time to Complete Activity:.50 Hours per Module

ACCESS THIS ACTIVITY

Independent Coverage from the 22nd International AIDS Conference (AIDS 2018)*

Activity Details

Independent Coverage from the 22nd International AIDS Conference (AIDS 2018)*

Activity Summary:
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

These educational Clinical Clips will spotlight the latest advances in the prevention and treatment of HIV and viral hepatitis through a series of daily, ‘what you need to know in 5-minutes’ videos from the 22nd International AIDS Conference (AIDS 2018) in Amsterdam, The Netherlands.

Faculty:Joseph Eron, Jr., MD

Accreditation Type:AMA, ANCC and ACPE

Release Date:July 24, 2018

Expiration Date: June 30, 2019

Estimated Time to Complete Activity:0.25 Hours per Clip

ACCESS THIS ACTIVITY

Thrombocytopenia in Chronic Liver Disease

Activity Details

Thrombocytopenia in Chronic Liver Disease

Activity Summary:
Thrombocytopenia is a common manifestation among patients with chronic liver disease. In the setting of advanced liver disease, thrombocytopenia may negatively impact patient care by interfering with diagnostic and therapeutic procedures. The development of thrombopoietin agonists has the potential to provide clinicians with new options to improve patient care. However, current guidelines provide limited guidance on the optimal approach to increase platelet counts in patients with chronic liver disease.

These educational Mini Modules will outline the pathophysiologic mechanisms, platelet threshold levels, and other factors that impact the decision to initiate treatment for thrombocytopenia. In addition, the benefits and limitations of current and emerging therapeutic options will be discussed.

Faculty:Fred Poordad, MD

Accreditation Type:AMA and ANCC

Release Date:June 14, 2018

Expiration Date: May 31, 2019

Estimated Time to Complete Activity:0.5 Hours per Module

ACCESS THIS ACTIVITY

Independent Conference Coverage from The American Thoracic Society (ATS) International Conference 2018*

Activity Details

Independent Conference Coverage from The American Thoracic Society (ATS) International Conference 2018*

Activity Summary:
Despite dramatic advances in the development of treatments for pulmonary arterial hypertension (PAH), it remains a chronic life-threatening illness for which there is no cure. Advances in knowledge within field are eagerly anticipated.

These educational Clinical Clips will spotlight important research into the basic science, diagnosis, treatment, and medical management of patients with PAH based on data presented at the American Thoracic Society (ATS) International Conference in San Diego, California, May 19-23 2018, through a series of two ‘what you need to know in 5-minutes’ videos.

Faculty:Murali Chakinala, MD

Accreditation Type:AMA, ANCC and ACPE

Release Date:May 20, 2018

Expiration Date: April 30, 2019

Estimated Time to Complete Activity:0.25 Hours per Clip

ACCESS THIS ACTIVITY

New Directions in the Treatment of Cystic Fibrosis: CFTR Modulator Therapy

Activity Details

New Directions in the Treatment of Cystic Fibrosis: CFTR Modulator Therapy

Activity Summary:
The introduction of cystic fibrosis transmembrane regulator (CFTR) modulator therapy represented a true break¬through in overcoming the genetic defects underlying cystic fibrosis (CF). Small-molecule therapy with a single agent, and a combination of that agent with a second complementary agent, has successfully improved meaningful clinical outcomes in patients with specific CF genotypes. This success has led to intensive research and development efforts to expand treatment options to broader populations of CF patients. As new agents become available, clinicians will need to make informed decisions about selecting appropriate therapy for individual CF patients.

These educational Mini Modules will outline the use of current CFTR modulator therapies, expectations for addressing unmet clinical needs with new therapies, and issues around integrating new therapies into clinical practice.

Faculty:Michael Schechter, MD, MPH

Accreditation Type:AMA, ANCC and ACPE

Release Date:May 10, 2018

Expiration Date: April 30, 2019

Estimated Time to Complete Activity:.50 Hours per Module

ACCESS THIS ACTIVITY

Independent Conference Coverage from the 53rd Annual Congress of the European Association for the Study of the Liver (EASL)*

Activity Details

Independent Conference Coverage from the 53rd Annual Congress of the European Association for the Study of the Liver (EASL)*

Faculty:Robert S. Brown, Jr., MD, MPH

Accreditation Type:AMA, ANCC and ACPE

Release Date:April 12, 2018

Expiration Date: March 31, 2019

Estimated Time to Complete Activity:0.25 Hours per Clip

ACCESS THIS ACTIVITY

Optimal Management of HIV Disease & Hepatitis: Clinical Conference XXVI (OPMAN) – Enduring Video Archive

Activity Details

Optimal Management of HIV Disease & Hepatitis: Clinical Conference XXVI (OPMAN) – Enduring Video Archive

Activity Summary:
We are pleased to have recently held the Optimal Management of HIV Disease & Hepatitis: Clinical Conference XXVI (OPMAN). The conference took place March 23-25, 2018, in Orlando, Florida with 15 of the leading clinicians and researchers in HIV and hepatitis medicine presenting an array of topics covering HIV disease, hepatitis and HIV-hepatitis coinfection. The presentations offered a unique distillation of clinically focused data tailored for practicing HIV and hepatitis healthcare professionals.

These certified CME/CE enduring video archives of OPMAN XXVI provide access to each day of the conference, including the clinical presentations, interactive case discussions and panel discussions addressing audience and faculty questions. CME/CE credit is provided separately by section so you can participate in only those sections of interest to you. We hope you enjoy this activity.

Faculty:Michael S. Saag, MD and Mark S. Sulkowski, MD

Accreditation Type:AMA, ANCC and ACPE

Release Date:April 3, 2018

Expiration Date: April 2, 2019

Estimated Time to Complete Activity:10.5 Hours

ACCESS THIS ACTIVITY

Practical Management of Pulmonary Arterial Hypertension:<br />Special Clinical Situations

Activity Details

Practical Management of Pulmonary Arterial Hypertension:<br />Special Clinical Situations

Activity Summary:
PAH patients have a wide variety of both ongoing and acute-care clinical needs. A variety of special clinical situations present themselves in this population.

These educational Mini Modules will outline clinical situations that include issues related to weight management and the development/recognition of sleep apnea in patients with PAH; treatment of atrial fibrillation/atrial flutter; preventing and managing acute respiratory infections; and issues related to the delivery of intravenous prostacyclins.

Faculty:David Badesch, MD

Accreditation Type:AMA, ANCC and ACPE

Release Date:March 22, 2018

Expiration Date: February 28, 2019

Estimated Time to Complete Activity:.50 Hours per Module

ACCESS THIS ACTIVITY

Independent Coverage from the Conference on Retroviruses and Opportunistic Infections (CROI)*

Activity Details

Independent Coverage from the Conference on Retroviruses and Opportunistic Infections (CROI)*

Faculty:Eric Daar, MD and Paul Sax, MD

Accreditation Type:AMA, ANCC and ACPE

Release Date:March 11, 2018

Expiration Date: February 28, 2019

Estimated Time to Complete Activity:0.25 Hours per Clip

ACCESS THIS ACTIVITY

Challenges and Approaches to Adherence with CFTR Modulator Therapy

Activity Details

Challenges and Approaches to Adherence with CFTR Modulator Therapy

Activity Summary:
Recently, modulators of the cystic fibrosis transmembrane regulator (CFTR) have been introduced as new therapy options for patients with cystic fibrosis (CF). Initial clinical experience with these agents indicates that their administration can be challenging to manage, being associated with adverse reactions in some patients. Some patients also have difficulty maintaining adherence to dosing regimens required for CFTR modulators and regimens involving co-administration of other chronic CF therapies.

This educational Mini Module will outline practical, clinically applicable approaches for minimizing and managing adverse events associated with CFTR modulators and for optimizing adherence.

Faculty:Clement L. Ren, MD, MBA

Accreditation Type:AMA, ANCC and ACPE

Release Date:March 8, 2018

Expiration Date: February 28, 2019

Estimated Time to Complete Activity:.50 Hours per Module

ACCESS THIS ACTIVITY

Conversations in HCV: Evolving Treatment Options

Activity Details

Conversations in HCV: Evolving Treatment Options

Activity Summary:
New pan-genotypic regimens continue to transform HCV management with more potent, more convenient, and safer regimens. These rapid changes require clinicians to become continually educated on the state-of-the-art approach to HCV management as well as safe and appropriate use of these newer regimens.

These Conversations in HCV will discuss the use of 8- or 12-week HCV regimens in treatment-naïve patients, HCV management issue in contemporary difficult-to-cure patients, and considerations in the setting of renal disease, HCC, and transplantation.

Faculty:Robert S. Brown, Jr., MD, David Nelson, MD, Nancy Reau, MD

Accreditation Type:Expired Activity

Release Date:Expired Activity

Expiration Date: Expired Activity

Estimated Time to Complete Activity:Expired Activity

ACCESS THIS ACTIVITY

Patient Care Approaches: Special Populations in HCV

Activity Details

Patient Care Approaches: Special Populations in HCV

Activity Summary:
This certified CME/CNE Interactive Case Review will address epidemiologic trends using a case-based approach to discuss optimal HCV therapy options and management approaches/challenges for patients with these various conditions.

Dr. Brown and Dr. Sulkowksi will discuss screening, prevention and treatment of hepatitis C virus (HCV) infection among special patient populations. Approaches necessary to achieve successful treatment of HCV in patients with HBV coinfection, HIV coinfection, advanced liver disease, and concomitant renal disease will be reviewed. Each Interactive Case has thought-provoking questions from the faculty built into the end giving users the opportunity to test their understanding of the material presented.

Faculty:Robert S. Brown Jr., MD, MPH and Mark Sulkowski, MD

Accreditation Type:AMA and ANCC

Release Date:Expired Activity

Expiration Date: Expired Activity

Estimated Time to Complete Activity:0.25 hours per Case

ACCESS THIS ACTIVITY

CME/CE Activity Sorter
(Select therapeutic category and activity type of interest and view your sorted activities below)

Your Sorted CME/CE Activities

Quarterly Brief (October - December, 2018): A Current Expert Analysis on Important HIV Clinical Decisions

Independent Conference Coverage from the 2018 Annual Meeting of the American Association for the Study of Liver Disease (AASLD)*

Pulmonary Hypertension for Urgent Care / Emergency Providers

Independent Coverage from HIV Drug Therapy, Glasgow 2018*

Advanced Topics in Pulmonary Arterial Hypertension II – Updated 10/25/18

Quality of Life and Patient-Reported Outcomes in PAH

Quarterly Brief (July-September, 2018):<br> A Current Expert Analysis on Important HIV Clinical Decisions

Independent Conference Coverage from the American College of Chest Physicians Annual Meeting 2018*

Pediatric Pulmonary Vascular Disease

Independent Coverage from the 22nd International AIDS Conference (AIDS 2018)*

Thrombocytopenia in Chronic Liver Disease

Independent Conference Coverage from The American Thoracic Society (ATS) International Conference 2018*

New Directions in the Treatment of Cystic Fibrosis: CFTR Modulator Therapy

Independent Conference Coverage from the 53rd Annual Congress of the European Association for the Study of the Liver (EASL)*

Optimal Management of HIV Disease & Hepatitis: Clinical Conference XXVI (OPMAN) – Enduring Video Archive

Practical Management of Pulmonary Arterial Hypertension:<br />Special Clinical Situations

Independent Coverage from the Conference on Retroviruses and Opportunistic Infections (CROI)*

Challenges and Approaches to Adherence with CFTR Modulator Therapy

Conversations in HCV: Evolving Treatment Options

Patient Care Approaches: Special Populations in HCV